GABPA and metabolic dysfunction-associated steatotic liver disease: Nine TFs (ETS1, SP1, GABPA, NFY, ELF1, ELK4, ELK5, Fil1 and PU.1) were predicted to be key factors in the process of BMP9 alleviating NAFLD.